These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17763142)

  • 21. Effects of droplet size and type of binder on the agglomerate growth mechanisms by melt agglomeration in a fluidised bed.
    Seo A; Holm P; Schaefer T
    Eur J Pharm Sci; 2002 Aug; 16(3):95-105. PubMed ID: 12128162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of melting and rheological properties of fatty binders on the melt granulation process in a high-shear mixer.
    Evrard B; Amighi K; Beten D; Delattre L; Moës AJ
    Drug Dev Ind Pharm; 1999 Nov; 25(11):1177-84. PubMed ID: 10596355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of agglomerated carvedilol by hot-melt processes in a fluid bed and high shear granulator.
    Kukec S; Dreu R; Vrbanec T; Srčič S; Vrečer F
    Int J Pharm; 2012 Jul; 430(1-2):74-85. PubMed ID: 22486965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Power consumption profiles in high-shear wet granulation. I: Liquid distribution in relation to powder and binder properties.
    Pepin X; Blanchon S; Couarraze G
    J Pharm Sci; 2001 Mar; 90(3):322-31. PubMed ID: 11170025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of melt pelletization in a high shear mixer.
    Bukovec P; Kroselj V; Turk S; Vrecer F
    Int J Pharm; 2009 Nov; 381(2):192-8. PubMed ID: 19580855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of budesonide nanocluster dry powder aerosols: preformulation.
    El-Gendy N; Selvam P; Soni P; Berkland C
    J Pharm Sci; 2012 Sep; 101(9):3434-44. PubMed ID: 22623018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between the effective interparticulate contact area and the tensile strength of tablets of amorphous and crystalline lactose of varying particle size.
    Sebhatu T; Alderborn G
    Eur J Pharm Sci; 1999 Aug; 8(4):235-42. PubMed ID: 10425373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the influence of alpha-lactose monohydrate particle morphology on granule and tablet properties after roll compaction/dry granulation.
    Grote S; Kleinebudde P
    Pharm Dev Technol; 2019 Mar; 24(3):314-322. PubMed ID: 29757067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To Evaluate the Effect of Solvents and Different Relative Humidity Conditions on Thermal and Rheological Properties of Microcrystalline Cellulose 101 Using METHOCEL™ E15LV as a Binder.
    Jagia M; Trivedi M; Dave RH
    AAPS PharmSciTech; 2016 Aug; 17(4):995-1006. PubMed ID: 26729530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine powder flow under humid environmental conditions from the perspective of surface energy.
    Karde V; Ghoroi C
    Int J Pharm; 2015 May; 485(1-2):192-201. PubMed ID: 25772418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shear-induced APAP de-agglomeration.
    Llusa M; Levin M; Snee RD; Muzzio FJ
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1487-95. PubMed ID: 19929208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melt pelletization with polyethylene glycol in a rotary processor.
    Vilhelmsen T; Kristensen J; Schaefer T
    Int J Pharm; 2004 May; 275(1-2):141-53. PubMed ID: 15081145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Powder strength distributions for understanding de-agglomeration of lactose powders.
    Das SC; Behara SR; Bulitta JB; Morton DA; Larson I; Stewart PJ
    Pharm Res; 2012 Oct; 29(10):2926-35. PubMed ID: 22695732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blending of agglomerates into powders 1: Quantification of abrasion rate.
    Willemsz TA; Oostra W; Hooijmaijers R; de Vegt O; Morad N; Vromans H; Frijlink HW; Van der Voort Maarschalk K
    Int J Pharm; 2010 Mar; 387(1-2):87-92. PubMed ID: 20015470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental study of wet granulation in fluidized bed: impact of the binder properties on the granule morphology.
    Rajniak P; Mancinelli C; Chern RT; Stepanek F; Farber L; Hill BT
    Int J Pharm; 2007 Apr; 334(1-2):92-102. PubMed ID: 17207948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of a viscous binder during high shear granulation--sensitivity to the method of delivery and its impact on product properties.
    Tan BM; Loh ZH; Soh JL; Liew CV; Heng PW
    Int J Pharm; 2014 Jan; 460(1-2):255-63. PubMed ID: 24269207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compression shear strength and tableting behavior of microcrystalline cellulose agglomerates modulated by a solution binder (polyethylene glycol).
    Nicklasson F; Alderborn G
    Pharm Res; 2001 Jun; 18(6):873-7. PubMed ID: 11474794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A drop penetration method to measure powder blend wettability.
    Wang Y; Liu Z; Muzzio F; Drazer G; Callegari G
    Int J Pharm; 2018 Mar; 538(1-2):112-118. PubMed ID: 29253584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of starting material particle size on its agglomeration behavior in high shear wet granulation.
    Badawy SI; Hussain MA
    AAPS PharmSciTech; 2004 May; 5(3):e38. PubMed ID: 15760071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.